Analytical Data
-
基因名
C14orf45
- Application
-
别名
BBOF1; C14orf45; CCDC176Basal body-orientation factor 1; Coiled-coil domain-containing Protein 176
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8ND07
-
表达区间
1-228 aa
-
氨基酸序列
MTKEFESEVLKLQQHAMIENQAGQVEIDKLQHLLQMKDREMNRVKKLAKNILDERTEVERFFLDALHQVKQQILISRKHYKQIAQAAFNLKMRAACTGRTEYPKIRTFDGREHSTNSVNQDLLEAEKWTHIEGNVDIGDLTWEQKEKVLRLLFAKMNGCPSRKYNQSSRPPVPDYVVSDSGETKEFGDESKLQDKIFITQQIAISDSSGEVVLPTIPKEPQESDTGTF
-
分子量
52.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C14orf45, a gene located on chromosome 14, has garnered increasing attention in recent years due to its potential roles in various biological processes and its implications in human diseases. Early studies suggested that C14orf45 might be involved in cellular functions such as apoptosis, cell proliferation, and immune response, which highlights its significance in maintaining cellular homeostasis. Furthermore, emerging evidence indicates that mutations or dysregulation of C14orf45 may be linked to certain cancers and neurodegenerative disorders. The exploration of C14orf45 recombinant protein has opened new avenues for understanding its functional mechanisms. By producing and characterizing recombinant C14orf45, researchers aim to elucidate its structure, interaction with other molecules, and the pathways it influences. This research not only contributes to the fundamental knowledge of C14orf45 but also holds promise for potential therapeutic interventions. As studies continue to unfold, C14orf45 may become a valuable biomarker or therapeutic target in the context of disease.
